Nicholas Cooper

Title: Innovations by Nicholas Cooper in Psychiatric Treatment

Introduction

Nicholas Cooper is an accomplished inventor based in Los Altos, CA. He has made significant contributions to the field of psychiatric treatment, particularly in addressing depression. With a total of 2 patents, his work focuses on innovative approaches to improve mental health outcomes for patients.

Latest Patents

One of Nicholas Cooper's latest patents involves the effective treatment of depression in patients who have impaired learning and/or memory or certain EEG characteristics. This invention utilizes (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone, also known as NSI-189, or a pharmaceutically acceptable salt thereof. The treatment targets psychiatric conditions where depressive symptoms are prominent, including major depressive disorder (MDD), bipolar disorder, post-traumatic stress disorder, substance use disorder, and depression-related aspects of schizophrenia. The invention emphasizes the importance of selecting patients who exhibit impaired learning and/or memory or specific EEG characteristics for optimal results.

Career Highlights

Nicholas Cooper is currently associated with Alto Neuroscience, Inc., where he continues to develop innovative solutions for mental health challenges. His work is characterized by a commitment to advancing psychiatric treatment through scientific research and innovation.

Collaborations

Cooper collaborates with notable colleagues in the field, including Amit Etkin and Wei Wu. Their combined expertise contributes to the development of effective treatments for mental health disorders.

Conclusion

Nicholas Cooper's contributions to psychiatric treatment through his innovative patents highlight the potential for new therapies in addressing depression and related conditions. His work at Alto Neuroscience, Inc. and collaborations with esteemed colleagues further underscore his commitment to improving mental health outcomes.